BRASH Syndrome

BRASH Syndrome: Break the Cycle

Core Concept

• BRASH syndrome is a self-reinforcing clinical cycle involving:
• Bradycardia
• Renal failure
• Atrioventricular nodal blockade
• Shock
• Hyperkalemia
• The acronym identifies the major components, but the key pathophysiology is their synergy.
• The resulting bradycardia may be disproportionate to the degree of hyperkalemia or medication exposure considered in isolation.

How the Cycle Develops

• A precipitant commonly initiates the cycle, such as dehydration, gastroenteritis, excessive diuresis, or another cause of reduced renal perfusion.
• Hypovolemia causes acute kidney injury.
• Kidney injury reduces potassium excretion and decreases clearance of AV-nodal blocking medications.
• Hyperkalemia and retained medications synergistically depress cardiac nodal activity.
• Relevant medications may include beta blockers, non-dihydropyridine calcium-channel blockers, digoxin, and amiodarone.
• Slower heart rate reduces cardiac output, further worsening renal perfusion, kidney injury, potassium retention, and medication accumulation.
• The self-perpetuating loop can deteriorate rapidly into hypotension and shock.

Who Is at Risk?

• Consider BRASH particularly in older adults, patients with multiple comorbidities, patients taking combinations of AV-nodal blocking medications, and patients with chronic kidney disease.
• ACE inhibitors, angiotensin-receptor blockers, and nonsteroidal anti-inflammatory drugs may further reduce renal reserve or impair potassium handling.

Typical Clinical Pattern

• Reported findings may include a heart rate of approximately 30 to 50 beats per minute, hypotension, elevated creatinine, and potassium of approximately 5.5 to 6.5.
• A source-based diagnostic framework includes heart rate below 60, potassium above 5.0, elevated creatinine or known chronic kidney disease, exposure to at least one AV-nodal blocker, and hypotension.
• These criteria organize recognition but do not replace clinical assessment. Always evaluate for alternative or additional causes of unstable bradycardia.

Diagnostic Pitfalls

• Do not dismiss clinically important BRASH because the potassium elevation appears only mild or moderate in isolation.
• Do not assume that a prescribed AV-nodal blocker represents intentional overdose or that the medication alone fully explains the presentation.
• The central error is treating one abnormality while leaving hypovolemia, malperfusion, bradycardia, hyperkalemia, or medication accumulation unchecked.
• Think of BRASH as a cycle that must be interrupted, not as isolated bradycardia plus an incidental laboratory abnormality.

Management: Interrupt Several Links at Once

Stabilize the Myocardium

• For moderate to severe hyperkalemia, give intravenous calcium when indicated, using calcium gluconate or calcium chloride.
• Calcium stabilizes the myocardium and may produce a dramatic improvement in heart rate by counteracting membrane effects within the combined syndrome.

Shift Potassium Intracellularly

• Use insulin plus glucose and a beta agonist when appropriate.
• Arrange repeat clinical and laboratory assessment after treatment.

Correct the Hemodynamic Trigger

• Temporarily hold or reduce contributing AV-nodal blocking medications while the acute physiology is corrected.
• Many patients are volume depleted. Give fluids thoughtfully while monitoring for oliguria, volume overload, and worsening renal function.
• The source lists normal saline or isotonic sodium bicarbonate as fluid options in this context.
• It describes isotonic bicarbonate as 150 mL of 8.4% sodium bicarbonate in 850 mL of dextrose water.
• Fluid choice and volume must be individualized to the patient’s hemodynamics, renal function, urine output, and risk of overload.

Consider Renal Replacement Therapy

• Consider dialysis for refractory hyperkalemia, severe acute kidney injury, or volume overload despite initial corrective measures.

Bradycardia and Pacing

• Avoid reflexively treating the presentation as standard isolated bradycardia before addressing hyperkalemia and the broader physiology.
• Omitting calcium initially may lead to unnecessary temporary pacing.
• Heart rate often improves after the feedback loop is interrupted, so pacing is frequently unnecessary.
• Persistent instability still requires continuous reassessment and escalation appropriate to the patient’s response and competing diagnoses.

Bedside Checklist

• Review the medication list for AV-nodal blockers and drugs that impair renal potassium handling.
• Ask about recent dehydration, gastroenteritis, diuresis, and reduced oral intake.
• Compare current and baseline creatinine and renal function.
• Interpret potassium together with the rhythm and hemodynamic state.
• Assess perfusion, urine output, volume status, and signs of shock.
• Treat hyperkalemia and myocardial instability promptly when clinically indicated.
• Reassess after each intervention rather than focusing on a single laboratory value.
• Consider dialysis when hyperkalemia, kidney injury, or volume overload remains refractory.

Clinical Pearls

• BRASH is a synergy syndrome, not simply severe hyperkalemia or isolated AV-nodal blocker toxicity.
• Mild or moderate hyperkalemia can still produce profound bradycardia when renal failure and AV-nodal blockade coexist.
• The medication dose may be therapeutic, yet the clinical effect may become excessive after renal dysfunction develops.
• Calcium can be both a treatment for hyperkalemic membrane toxicity and a rapid diagnostic-therapeutic maneuver.
• Breaking the cycle requires simultaneous attention to potassium, perfusion, volume status, renal failure, and medication accumulation.

Bottom Line

When bradycardia occurs with renal dysfunction, hyperkalemia, hypotension, and exposure to an AV-nodal blocker, recognize BRASH syndrome early. Treat the interacting physiology rather than one abnormality in isolation: stabilize the myocardium, shift potassium, restore appropriate perfusion, reassess medications, and consider dialysis when initial measures fail.

---

Prepared from the source note provided by the user. Treatment details and diagnostic thresholds should be checked against local protocols and the original source before formal clinical use.

Febrile Seizures

Febrile Seizures: Evaluation and Teaching

Definition of a Simple Febrile Seizure

• Simple febrile seizures occur in neurologically healthy children who return to baseline after a fever-associated seizure.
• The simple pattern is generalized, lasts less than 15 minutes, occurs once within 24 hours, and leaves no persistent focal neurologic deficit.
• Classify cautiously because atypical age, focal activity, prolonged activity, recurrence within 24 hours, delayed recovery, or an abnormal neurologic examination changes the diagnostic problem.

During the Active Seizure

• Prioritize airway, breathing, circulation, safe positioning, and removal of hazards.
• Place the child safely on the side when practical. Observe breathing and color.
• Document the time of onset, duration, focal features, and recovery pattern.
• Do not restrain the child or place anything in the child’s mouth.
• An ongoing prolonged seizure requires treatment under the local pediatric seizure protocol without delay.

Assessment After the Event

• Confirm progressive recovery toward the child’s baseline and identify the source of fever.
• When suggested by the history or examination, evaluate for meningitis, encephalitis, sepsis, trauma, toxic exposure, hypoglycemia, metabolic disturbance, or another seizure mimic.
• A typical simple febrile seizure alone does not mandate routine electroencephalography, blood testing, or neuroimaging.
• Investigations should be driven by the clinical evaluation of the child and the fever source.

Lumbar Puncture

• Perform lumbar puncture when signs or symptoms raise concern for meningitis.
• In children 6 to 12 months of age, lumbar puncture is an option when Haemophilus influenzae type b or pneumococcal immunization is deficient or unknown.
• Lumbar puncture is also an option after antibiotic pretreatment because antibiotics may partially mask meningitis.
• Do not perform lumbar puncture routinely after a typical simple febrile seizure without clinical concern for meningitis.

Antipyretics: Comfort, Not Routine Seizure Prophylaxis

• Acetaminophen or ibuprofen may relieve fever-related distress.
• Before administration, consider age, weight, contraindications, product instructions, and local prescribing guidance.
• Do not promise that antipyretics prevent seizures during a later febrile illness.
• Avoid duplicate acetaminophen-containing products and dosing errors.
• Do not routinely give acetaminophen and ibuprofen simultaneously or alternate them as seizure prophylaxis.
• Consider changing agents, or alternating them only when distress persists or returns before the next dose is due, according to local guidance. This is a comfort strategy, not a routine seizure-prevention strategy.

Interpreting the Antipyretic Evidence

• One prospective, single-center, open randomized study reported fewer same-fever recurrences with a specified rectal acetaminophen regimen than with no antipyretic or placebo control.
• Do not generalize that result to scheduled oral antipyretic use at home for future illnesses.
• The regimen was rectal and protocol-specific. The study was single-center, open-label, and used a no-antipyretic control without placebo.
• These design features limit certainty and applicability. Use local pediatric prescribing guidance rather than extrapolating the finding indiscriminately.

Antiseizure Prophylaxis

• Routine continuous or intermittent antiseizure prophylaxis after a simple febrile seizure is generally unjustified.
• The limited benefit of preventing an often benign recurrence must be weighed against medication-related harms.
• Rescue-medication plans and emergency-call thresholds should follow local protocols and individualized medical plans.

Caregiver Teaching

• Use a safe, side-lying surface during a seizure when practical.
• Remove nearby hazards.
• Do not restrain the child or put objects or fingers in the child’s mouth.
• Time any further seizure carefully from onset.
• Reassure caregivers without minimizing danger.
• A changed seizure pattern or concerning examination warrants fresh evaluation rather than automatic labeling as a simple febrile seizure.

Escalation and Red Flags

• Escalate urgently for ongoing seizure activity, abnormal breathing or cyanosis, suspected serious illness, failure to recover progressively toward baseline, another seizure within 24 hours, or focal, prolonged, or otherwise atypical seizure features.
• Follow the local pediatric seizure protocol for emergency treatment and rescue medication.

Clinical Pearls

• The diagnosis of a simple febrile seizure depends on the full event and recovery pattern, not fever alone.
• Atypical age, focality, prolonged activity, recurrence, delayed recovery, or abnormal examination should prompt a broader differential diagnosis.
• Treat the child during an active prolonged seizure; do not wait for a complete diagnostic workup.
• Routine EEG, blood tests, and neuroimaging are not required solely because a typical simple febrile seizure occurred.
• Antipyretics improve comfort but should not be presented as reliable prevention of future febrile seizures.
• Caregiver education is a core intervention because unsafe responses can cause preventable harm.

Bottom Line

A typical simple febrile seizure is generalized, brief, isolated within 24 hours, and followed by return to baseline without a persistent focal deficit. Manage the active seizure safely, identify the fever source, investigate only when clinical features warrant it, provide comfort-focused fever treatment, and give clear red-flag instructions. Any deviation from the simple pattern requires reassessment rather than automatic reassurance.

---

Prepared from the source note provided by the user. Medication choices, dosing, emergency thresholds, and lumbar-puncture decisions should be checked against current local pediatric protocols before clinical use.

Hyperkalemia Management

Hyperkalemia Management: Stabilize, Shift, Remove

Why Hyperkalemia Is Dangerous

• Hyperkalemia is dangerous because electrical toxicity may progress from slowed conduction to malignant dysrhythmia or cardiac arrest.
• Treat the patient’s clinical risk, not an isolated potassium number.
• Urgent management is indicated when potassium is 6.5 mmol/L or higher.

Initial Assessment and Monitoring

• Obtain a 12-lead ECG when potassium is 6.0 mmol/L or higher.
• Use continuous cardiac monitoring for potassium 6.5 mmol/L or higher, any ECG abnormality, or a clinically unwell patient with potassium 6.0 to 6.4 mmol/L.
• ECG findings correlate imperfectly with serum potassium concentration and may reflect both the absolute level and the rate of rise.

ECG Toxicity

• Potential ECG manifestations include peaked T waves, PR prolongation, QRS widening, loss of P waves, bradycardia, a sine-wave pattern, ventricular fibrillation, and asystole.
• A normal ECG does not rule out dangerous hyperkalemia.
• Do not wait for a textbook tracing when the clinical context and laboratory result indicate risk.

First Pitfall: Pseudohyperkalemia

• Before treating a stable patient, consider whether the result is genuine.
• Check for hemolysis and collection or handling problems.
• Possible causes of a falsely elevated potassium include fist clenching, prolonged tourniquet time, small needles, delayed processing, thrombocytosis, leukocytosis, and sampling through a potassium-containing infusion.
• Whole-blood point-of-care testing is rapid but cannot identify hemolysis.
• If hemolysis is suspected, repeat a freshly drawn plasma sample.
• Do not delay resuscitation for confirmation when ECG toxicity or hemodynamic instability is present.

Step 1: Stabilize Cardiac Conduction

• For hyperkalemia with ECG changes, stabilize cardiac conduction before shifting potassium intracellularly.
• Calcium does not lower serum potassium.
• The local source sequence specifies 10 mL of 10% calcium chloride intravenously over 5 minutes for peri-arrest or cardiac arrest, or 30 mL of 10% calcium gluconate intravenously over 10 minutes otherwise.
• Administer calcium with cardiac monitoring.
• Calcium chloride is more caustic; calcium gluconate is generally preferred through peripheral access.
• Reassess the ECG and clinical response. Repeat calcium according to the local emergency protocol if toxicity persists.

Step 2: Shift Potassium Intracellularly

• For potassium 6.5 mmol/L or higher, the local sequence specifies regular insulin 10 units intravenously plus glucose 25 g intravenously.
• Expected onset is approximately 10 to 20 minutes.
• Nebulized salbutamol 10 to 20 mg is an adjunct, not monotherapy.
• Intravenous bicarbonate is not routine potassium-lowering therapy. Consider it for concurrent metabolic acidosis rather than hyperkalemia alone.
• Do not administer bicarbonate and calcium through the same unflushed line because precipitation may obstruct drug delivery.

Prevent Insulin-Associated Hypoglycemia

• Insulin-related hypoglycemia is predictable and requires an explicit monitoring plan.
• If baseline glucose is below 7.0 mmol/L, the local protocol follows insulin-glucose treatment with 10% glucose at 50 mL/hour for 5 hours and capillary glucose monitoring through 6 hours.
• Lower insulin doses have been associated with less hypoglycemia in retrospective cohorts, without a detected difference in potassium reduction. This evidence is not definitive.
• Follow the locally approved medication-safety pathway.

Step 3: Remove Potassium

• Intracellular shifting is temporary and does not remove potassium from the body.
• Recheck potassium at 1, 2, 4, 6, and 24 hours when response is inadequate or rebound is possible.
• Arrange urgent dialysis for life-threatening or medically refractory hyperkalemia, especially with severe acute kidney injury, oliguria, or persistent ECG toxicity.
• Potassium binders do not substitute for immediate calcium, shifting therapy, or dialysis in an unstable patient.
• The acute role of potassium binders remains uncertain.

Practical Treatment Sequence

• Stabilize: Give intravenous calcium for hyperkalemic ECG toxicity.
• Shift: Use insulin plus glucose, with nebulized salbutamol as an adjunct when appropriate.
• Remove: Arrange urgent dialysis when hyperkalemia is life-threatening or refractory.
• Monitor: Repeat ECG, potassium, glucose, renal function, urine output, and clinical perfusion assessment.
• Reassess: Look for rebound hyperkalemia and persistent or recurrent electrical toxicity.

Clinical Pearls

• A normal ECG cannot safely exclude severe hyperkalemia.
• Calcium protects the myocardium but does not lower potassium.
• Insulin and beta-agonists shift potassium temporarily; definitive management requires potassium removal.
• Confirm suspected pseudohyperkalemia when the patient is stable, but never allow confirmation to delay treatment of toxicity or shock.
• Avoid treating a potassium value without assessing the rhythm, renal function, perfusion, and trajectory.

Bottom Line

Manage dangerous hyperkalemia in three linked phases: stabilize the myocardium, shift potassium intracellularly, and remove potassium from the body. Continuous monitoring, glucose surveillance, repeat potassium measurements, and early dialysis planning are essential. All doses and treatment decisions must follow the locally approved emergency and renal-replacement protocols.

---

Doses, thresholds, and monitoring intervals reflect that source and should be checked against current local protocols before clinical use.

Wernicke-Korsakoff Syndrome

Wernicke-Korsakoff Syndrome Without the Classic Triad

Case Snapshot

• A 62-year-old woman with metastatic breast cancer was receiving pembrolizumab plus a STING agonist.
• Cancer imaging showed good disease control.
• Over approximately one month, she developed altered taste, dry mouth, severe anorexia, progressively reduced oral intake, and a 5-kg weight loss.
• She then developed anhedonia, rapidly worsening short-term memory, confabulation, and progressive gait instability requiring support from walls and furniture.
• Her BMI was 24 and serum albumin was normal.
• She had no heavy alcohol use, no obvious ocular-motor abnormality, and an initially unrevealing MRI.

Diagnostic Pivot

• Psychiatry was initially consulted to evaluate possible depression.
• Family history clarified the neurologic syndrome: she could no longer walk independently and had to hold onto furniture and walls.
• The key pattern was recent nutritional deterioration, severe anterograde amnesia, confabulation, and gait dysfunction.
• Wernicke encephalopathy with progression toward Korsakoff syndrome became the leading diagnosis.

Do Not Underestimate the Word “Fatigue”

• Patient-reported fatigue may represent tiredness, weakness, reduced motivation, exercise intolerance, balance impairment, or gait dysfunction.
• Ask function-based questions: What could the patient do one month ago that she cannot do now? Can she walk across the room without support? Can she prepare food, dress, bathe, and manage medications as before?
• Family observations may reveal the neurologic deficit more clearly than the patient’s description.

Attention Is Not the Same as Memory

• The patient could recite the days of the week backward, suggesting preserved performance on some attention and working-operation tasks.
• Five minutes later, she could not recall three objects, even with cues, and she exhibited confabulation.
• Attention concerns whether information can be registered and manipulated in the moment. New long-term memory concerns whether information can still be retrieved after a delay.
• Preserved attention does not exclude severe anterograde amnesia.

Wernicke Encephalopathy Is Not Limited to Alcohol Use

• Heavy alcohol use is an important risk factor, but it is not required.
• Other risk factors include starvation or markedly reduced intake, hyperemesis, critical illness, liver disease, immunodeficiency, cancer-related anorexia and malnutrition, and malabsorption.
• Thiamine stores can become depleted rapidly during severe dietary restriction, potentially within approximately two weeks.
• The month-long decline in intake in this case was temporally compatible with clinically important thiamine deficiency.

Do Not Wait for the Classic Triad

• The classic triad consists of mental-status change, ataxia, and ocular-motor abnormality.
• The complete triad is uncommon and has been reported in only about 10% to 16% of cases.
• Approximately 71% of patients may lack ophthalmoparesis or another ocular abnormality.
• Absence of eye findings is insufficient to exclude Wernicke encephalopathy.

Caine Criteria: A Practical Clinical Framework

• Strong clinical suspicion is warranted when at least two of the following are present:
• Evidence of nutritional deficiency
• Altered mental status or memory impairment
• Ocular-motor abnormality
• Cerebellar dysfunction
• This patient met the threshold through markedly reduced intake with weight loss and severe memory impairment with confabulation. Her gait instability provided additional support.
• The diagnosis is clinical. Laboratory and imaging studies should support the assessment, not delay treatment.

Normal BMI and Albumin Do Not Exclude Nutritional Neurologic Disease

• Nutritional risk is dynamic rather than a single static measurement.
• A normal BMI does not rule out acute nutritional depletion, and normal albumin does not guarantee adequate vitamin status or preserved muscle mass.
• Assess recent oral intake, rate and magnitude of weight loss, temporal wasting, other muscle loss, functional decline, malabsorption, and systemic illness.
• In this case, a BMI of 24 and normal albumin coexisted with a 5-kg weight loss and visible temporal wasting.

MRI: Helpful, but Neither Necessary nor Sufficient

• The first MRI showed an old left temporal-occipital infarct but no new lesion or obvious mammillary-body abnormality.
• A repeat MRI focused on the mammillary bodies showed bilateral, symmetric mammillary-body enhancement.
• The repeat study did not show the more classic medial-thalamic or periaqueductal FLAIR abnormalities.
• A normal initial MRI should not dismiss Wernicke encephalopathy. Even a second normal MRI would not exclude it.
• Imaging should be guided by a clinical hypothesis, not used as a prerequisite for treatment.

Wernicke Encephalopathy and Korsakoff Syndrome

• Wernicke encephalopathy is the acute neurologic syndrome associated with thiamine deficiency.
• Korsakoff syndrome reflects persistent, often severe memory dysfunction that may follow inadequately treated or prolonged Wernicke encephalopathy.
• Korsakoff syndrome does not necessarily present as global cognitive collapse.
• The defining impairment may be prominent or relatively isolated memory dysfunction with confabulation.
• A patient may converse fluently and perform selected attention tasks while having severe impairment in forming new memories.

Treatment Principle

• When Wernicke encephalopathy is suspected, administer parenteral thiamine promptly.
• Do not wait for a serum thiamine result, MRI confirmation, or the complete classic triad.
• Treatment delay can result in permanent neurologic injury, progression to Korsakoff syndrome, or death.
• In the reported case, one week of intravenous thiamine three times daily improved appetite and subjective well-being, but memory impairment persisted at two-week follow-up.
• Evaluate for concurrent nutritional deficiencies because malnutrition and malabsorption commonly involve multiple vitamin and mineral deficits.

Clinical Takeaways

• New anorexia plus memory loss, confabulation, or gait instability should trigger consideration of Wernicke encephalopathy.
• Lack of alcohol use, ocular findings, low BMI, or an abnormal initial MRI is not required for the diagnosis.
• Functional history from family members may be more localizing than the patient’s report of “fatigue.”
• Preserved attention does not rule out severe anterograde amnesia.
• Use the Caine criteria to structure bedside suspicion.
• Treat suspected Wernicke encephalopathy empirically with parenteral thiamine without waiting for confirmatory testing.

Bottom Line

When a patient has a recent decline in oral intake followed by memory loss, confabulation, or gait instability, Wernicke encephalopathy must remain on the differential even without alcohol misuse, ocular-motor findings, low BMI, or a classic MRI. The diagnosis is primarily clinical, and early parenteral thiamine may prevent irreversible neurologic injury.

---

Prepared from the clinical case summary provided by the user. Quantitative figures and treatment details are reproduced from that summary and should be checked against the original NEJM CPC before formal publication or bedside protocol use.